Impact of egg supplementation on growth and development of young children.
Not Applicable
- Registration Number
- CTRI/2021/11/038208
- Lead Sponsor
- ICMR National Institute of Nutrition
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Apparently healthy infants
•Willing to comply with the study
requirements and provide repeated
data/samples
•Intending to remain resident in the area
Exclusion Criteria
•Multiple pregnancy (e.g. twin/triplets)
•Known egg allergy
•Suspicion or presence of any acute illness (e.g. fever, receiving treatment with antibiotics)
•Congenital abnormality that might be life-threatening or impair growth
•mother unlikely to stay in study area for the duration of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength for age Z score <br/ ><br>Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method Blood levels of biomarkers <br/ ><br>1.Plasma growth hormones: insulin like growth factor (IGF)-1 and its carrier protein IGF binding protein 3 (IGFBP3) at 18 months <br/ ><br>2.Serum fatty acid profile including serum cholesterol at 18 months <br/ ><br>3.Nutritional biomarkers including serum/plasma concentrations of essential amino acids, essential fatty acids including DHA, retinol, folate, B12, choline, betaine <br/ ><br> <br/ ><br>Timepoint: 18 months;CognitionTimepoint: 18 months;Episodes of hospital admission and episodes of sick-child clinic visitsTimepoint: 12 and 18 months